| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/17425247.2.5.829 |
| P698 | PubMed publication ID | 16296781 |
| P2093 | author name string | H Oya Alpar | |
| Vincent W Bramwell | |||
| Irene Papanicolaou | |||
| P2860 | cites work | PUBLIC HEALTH: High Hopes and Dilemmas for a Cervical Cancer Vaccine | Q22299339 |
| DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations | Q24563751 | ||
| Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure | Q24634002 | ||
| Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors | Q27469662 | ||
| Expression of luciferase in selected organs following delivery of naked and formulated DNA to rainbow trout (Oncorhynchus mykiss) by different routes of administration | Q47659341 | ||
| Improved green fluorescent protein by molecular evolution using DNA shuffling | Q47961174 | ||
| Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. | Q52553636 | ||
| Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. | Q52844746 | ||
| Human hepatitis B vaccine from recombinant yeast | Q52850114 | ||
| Immobilization of plasmid DNA in bacterial ghosts. | Q54492172 | ||
| Efficient delivery of DNA to dendritic cells mediated by influenza virosomes | Q57762470 | ||
| Liposomes as immunological adjuvants | Q59068902 | ||
| Cancer therapy using a self-replicating RNA vaccine | Q27481056 | ||
| DNA vaccines: immunology, application, and optimization* | Q28145651 | ||
| The vacuolating virus, S.V. 40 | Q28187424 | ||
| Rapid evolution of a protein in vitro by DNA shuffling | Q28245873 | ||
| The efficacy of whole cell pertussis immunisation: collected data on a vaccine produced in France | Q30654190 | ||
| Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods | Q30969037 | ||
| Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines | Q33731344 | ||
| Vaccine entrapment in liposomes | Q33753592 | ||
| Myth, menace or medical blessing? The clinical potential and the problems of genetic vaccines | Q33757269 | ||
| Vaccines in historic evolution and perspective: a narrative of vaccine discoveries | Q33807651 | ||
| Vaccines, coming of age after 200 years | Q33820593 | ||
| Recent advances with recombinant bacterial vaccine vectors. | Q33826608 | ||
| Biodegradation and biocompatibility of PLA and PLGA microspheres | Q33933142 | ||
| Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara | Q33935092 | ||
| Directed evolution: the 'rational' basis for 'irrational' design. | Q34029169 | ||
| Aromatic-dependent salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them | Q34041923 | ||
| Formation of virosomes from influenza subunits and liposomes | Q34053696 | ||
| From evil to good: a cytolysin in vaccine development. | Q34134510 | ||
| Polysaccharide colloidal particles as delivery systems for macromolecules | Q34184373 | ||
| Live attenuated vaccines against influenza; an historical review | Q34248885 | ||
| Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency | Q34410118 | ||
| Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease | Q34693094 | ||
| Cationic microparticles: A potent delivery system for DNA vaccines | Q34978592 | ||
| Current status of DNA vaccines and their route of administration | Q35093421 | ||
| Technical and regulatory hurdles for DNA vaccines | Q35143252 | ||
| New approaches in vaccine development | Q35159086 | ||
| Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis | Q35159097 | ||
| Adjuvant formulations and delivery systems for DNA vaccines | Q35544653 | ||
| The use of bioabsorbable implants in the spine | Q35572893 | ||
| Electroporation for gene transfer to skeletal muscles: current status | Q35782833 | ||
| Biodegradable polyester elastomers in tissue engineering | Q35790829 | ||
| Attenuated salmonella and Shigella as carriers for DNA vaccines | Q35809245 | ||
| Progress in DNA-based heterologous prime-boost immunization strategies for malaria | Q35826388 | ||
| Microparticles for the delivery of DNA vaccines | Q35826399 | ||
| DNA vaccines to attack cancer | Q35855143 | ||
| Bacteria as DNA vaccine carriers for genetic immunization | Q35942935 | ||
| Formulation aspects of biodegradable polymeric microspheres for antigen delivery | Q35961150 | ||
| DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells | Q35961155 | ||
| Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens | Q35961159 | ||
| Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery | Q35961163 | ||
| Towards multifunctional synthetic vectors | Q35972148 | ||
| DNA minigene vaccination for adjuvant neuroblastoma therapy. | Q36009158 | ||
| Particulate delivery systems for vaccines | Q36111021 | ||
| Particulate delivery systems for biodefense subunit vaccines | Q36151625 | ||
| Live Salmonella as vaccines and carriers of foreign antigenic determinants | Q38211130 | ||
| Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components | Q38299533 | ||
| Symposium on smallpox eradication. Smallpox eradication-a narrative account | Q39954764 | ||
| Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine | Q40419782 | ||
| Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99. | Q40433851 | ||
| DNA vaccines: a novel approach to immunization. | Q40472575 | ||
| Increased resistance of DNA lipoplexes to protein binding in vitro by surface-modification with a multivalent hydrophilic polymer. | Q40476678 | ||
| Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine | Q40495028 | ||
| Protein expression in vivo by injection of polynucleotides | Q40535454 | ||
| Formulation and in vitro transfection efficiency of poly (D, L-lactide-co-glycolide) microspheres containing plasmid DNA for gene delivery | Q40598735 | ||
| Gram-positive and Gram-negative bacteria as carrier systems for DNA vaccines | Q40820067 | ||
| Evolution of a cytokine using DNA family shuffling | Q40938269 | ||
| Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes | Q40968546 | ||
| Mechanisms of polymer degradation and erosion | Q40983477 | ||
| Liposome-mediated DNA vaccination: the effect of vesicle composition | Q41630994 | ||
| A novel cationic liposome reagent for efficient transfection of mammalian cells | Q41668737 | ||
| A single-step immunization by sustained antigen release | Q41741707 | ||
| Polymers for the sustained release of proteins and other macromolecules | Q42102243 | ||
| Modulation of allergic responses in mice by using biodegradable poly(lactide-co-glycolide) microspheres | Q43483888 | ||
| Genetic immunization is a simple method for eliciting an immune response | Q43857336 | ||
| Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study | Q43983904 | ||
| Preparation and characterization of cationic PLGA nanospheres as DNA carriers. | Q44062476 | ||
| Jet milling--a new technique for microparticle preparation | Q44100916 | ||
| Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen | Q44105188 | ||
| Direct gene transfer into mouse muscle in vivo | Q44656494 | ||
| Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA. | Q44833577 | ||
| Immunogenic and protective effects of a DNA vaccine for Mycobacterium marinum in fish | Q44907344 | ||
| Transport of polymeric nanoparticle gene carriers in gastric mucus | Q44920664 | ||
| Cationic microparticles are a potent delivery system for a HCV DNA vaccine | Q45149602 | ||
| Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery | Q45264771 | ||
| Production in Saccharomycescerevisiae of MS2 virus-like particles packaging functional heterologous mRNAs | Q45484341 | ||
| Limitations of plasmid vaccines to complex viruses: selected myxoma virus antigens as DNA vaccines were not protective | Q45552969 | ||
| Codon optimization and ubiquitin conjugation of human immunodeficiency virus-1 Tat lead to enhanced cell-mediated immune responses | Q45628437 | ||
| DNA vaccination against respiratory influenza virus infection | Q45738170 | ||
| DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL). | Q45745832 | ||
| Synthesis and assembly of hepatitis B virus surface antigen particles in yeast | Q45793098 | ||
| Preparation of liposomes containing factor VIII for oral treatment of haemophilia | Q45862869 | ||
| Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. | Q45884084 | ||
| Plasmid DNA activates murine macrophages to induce inflammatory cytokines in a CpG motif-independent manner by complex formation with cationic liposomes. | Q45886828 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 829-842 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Expert Opinion on Drug Delivery | Q5421203 |
| P1476 | title | Strategies for DNA vaccine delivery | |
| P478 | volume | 2 |
| Q34544509 | Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems. |
| Q40451608 | CNA-loaded PLGA nanoparticles improve humoral response againstS. aureus-mediated infections in a mouse model: subcutaneous vs. nasal administration strategy. |
| Q57373962 | DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination |
| Q40465530 | Dengue tetravalent DNA vaccine increases its immunogenicity in mice when mixed with a dengue type 2 subunit vaccine or an inactivated Japanese encephalitis vaccine. |
| Q40180794 | Fusion of antigen to Fas-ligand in a DNA vaccine enhances immunogenicity |
| Q44364556 | Inclusion of the viral anti-apoptotic molecule M11L in DNA vaccine vectors enhances HIV Env-specific T cell-mediated immunity. |
| Q38517950 | Nanoengineering of vaccines using natural polysaccharides. |
| Q36662462 | Progress and obstacles in the development of an AIDS vaccine |
Search more.